Following the tragic incident involving the CEO of UnitedHealthcare, investigators are diligently examining crucial pieces of evidence related to the weapon used in the attack. The weapon, believed to be a firearm, left behind shell casings and bullets at the scene, which could provide vital information in identifying the perpetrator.
According to experts, firearms leave distinct markings on both the bullet and the shell casing, akin to a unique fingerprint. By analyzing these markings, investigators hope to gain insights into the type of firearm used and potentially link it to past criminal activities.
The shooting took place as CEO Brian Thompson was walking to a Midtown hotel, where he was approached from behind by the assailant. The gunman fired multiple shots, hitting Thompson at least once in the back and once in the right calf. The shooter even unjammed the gun during the attack, indicating a premeditated and calculated act.
In addition to the New York Police Department (NYPD), the federal Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) may also be involved in the investigation to assist in identifying the unique markings on the casings and bullets. By cross-referencing their findings with a database of firearms used in previous crimes, investigators aim to rule out any connections to past incidents.
Despite the apparent planning that went into the attack, law enforcement officials believe that the shooter cannot control the evidence left behind by the firearm. This evidence, in the form of shell casings and bullets, could be instrumental in unraveling the mystery behind the motive and identity of the perpetrator.
